Latest Breaking News On - பேகிங் தொழிற்சங்கம் மருத்துவ கல்லூரி மருத்துவமனை - Page 4 : vimarsana.com

 E-Mail Neuroendocrine tumours are cancers that begin in specialised cells called neuroendocrine cells. These cells have traits similar to those of nerve cells and hormone-producing cells. Neuroendocrine tumours, while rare, can occur anywhere in the body. Most affect the cardiothoracic region, eg lungs, appendix, small intestine, pancreas as well as the rectum. There are many types of neuroendocrine tumours: some grow slowly while others develop very rapidly. Neuroendocrine tumors are characterised by abundant production of somatostatin receptor 2, a naturally circulating hormone that is an important target for scientists studying new treatment approaches. Peptide Receptor Radionuclide Therapy (PRRT) is the most commonly used treatment for refractive neuroendocrine cancers, delivering cancer-killing radioactive substances directly to tumour sites. This treatment provides symptomatic relief, stopping or slowing tumour growth and improving overall survival for patients. It is a fo

Shawn chen xiaoyuanMolecular targeting technologies incJournal of nuclear medicineChinese academy of medical scienceNational university hospitalYong loo lin school of medicineDepartment of biomedical engineeringDrug administrationUnion medical college hospitalNational university of singaporeDepartment of diagnostic radiologyReceptor radionuclide therapyPeking union medical college hospitalChinese academyMedical scienceProfessor shawn chen xiaoyuan